- Home
- NXDT vs CATX Comparison
NXDT vs CATX Comparison
Compare NXDT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXDT | CATX |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.0M | 162.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NXDT | CATX |
|---|---|---|
| Price | $3.70 | $2.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 133.6K | ★ 1.9M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | N/A | ★ $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.41 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.89 | $1.60 |
| 52 Week High | $13.07 | $5.39 |
Technical Indicators
Market Signals| Indicator | NXDT | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 53.22 |
| Support Level | $2.65 | $2.07 |
| Resistance Level | $3.70 | $2.89 |
| Average True Range (ATR) | 0.26 | 0.19 |
| MACD | 0.11 | 0.08 |
| Stochastic Oscillator | 90.04 | 61.31 |
Price Performance
Historical ComparisonAbout NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.